Discovery of the First-in-Class GSK-3βHDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease by unknow

Discovery of the First-in-Class GSK-3βHDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease by unknow

Author:unknow
Format: pdf
Tags: ACS Med. Chem. Lett. 2019.10:469-474, Polypharmacology, epigenetics, dual binding agents, glycogen synthase kinase 3β, histone deacetylases, neuroprotection
Publisher: American Chemical Society
Published: 2019-04-04T14:15:34+00:00


Download



Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.